Review



p nfκb  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Cell Signaling Technology Inc p nfκb
    P Nfκb, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 7464 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p nfκb/product/Cell Signaling Technology Inc
    Average 99 stars, based on 7464 article reviews
    p nfκb - by Bioz Stars, 2026-02
    99/100 stars

    Images



    Similar Products

    95
    Bioss rabbit anti nfκb p p65
    CSF3 enhances the immune response to ALV-J via the NFκB signaling pathway. (A) Western blot analysis of p52, p100, phosphorylated <t>p65</t> (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 overexpression in DF-1 cells. (B) Quantification of protein levels in (A) based on relative grayscale values. (C) Western blot analysis of p52, p100, phosphorylated p65 (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 knockdown in DF-1 cells. (D) Quantification of protein levels in (C) based on relative grayscale values. (D, E) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (D) or knockdown (E) in DF-1 cells. (F, G) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (F) or knockdown (G) in DF-1 cells. (H, I) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (H) or knockdown (I) in CEF cells. (J, K) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (J) or knockdown (K) in CEF cells. (L) Western blot analysis of STAT3, phosphorylated STAT3 (p-STAT3), env, β-actin, IκBα, p-IκBα, p-p65, p52, and p100 after STAT3 phosphorylation inhibition in CSF3-overexpressing DF-1 cells. (M) Quantification of protein levels in (L) based on relative grayscale values. Statistical significance was determined using a two-tailed unpaired Student’s t-test ( p < 0.05). * p < 0.05, **p < 0.01, *** p < 0.001.
    Rabbit Anti Nfκb P P65, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti nfκb p p65/product/Bioss
    Average 95 stars, based on 1 article reviews
    rabbit anti nfκb p p65 - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    95
    Bioss p nfκb p65
    CSF3 enhances the immune response to ALV-J via the NFκB signaling pathway. (A) Western blot analysis of p52, p100, phosphorylated <t>p65</t> (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 overexpression in DF-1 cells. (B) Quantification of protein levels in (A) based on relative grayscale values. (C) Western blot analysis of p52, p100, phosphorylated p65 (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 knockdown in DF-1 cells. (D) Quantification of protein levels in (C) based on relative grayscale values. (D, E) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (D) or knockdown (E) in DF-1 cells. (F, G) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (F) or knockdown (G) in DF-1 cells. (H, I) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (H) or knockdown (I) in CEF cells. (J, K) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (J) or knockdown (K) in CEF cells. (L) Western blot analysis of STAT3, phosphorylated STAT3 (p-STAT3), env, β-actin, IκBα, p-IκBα, p-p65, p52, and p100 after STAT3 phosphorylation inhibition in CSF3-overexpressing DF-1 cells. (M) Quantification of protein levels in (L) based on relative grayscale values. Statistical significance was determined using a two-tailed unpaired Student’s t-test ( p < 0.05). * p < 0.05, **p < 0.01, *** p < 0.001.
    P Nfκb P65, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p nfκb p65/product/Bioss
    Average 95 stars, based on 1 article reviews
    p nfκb p65 - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    94
    Bioss rabbit polyclonal antibody against p nfκb ser536
    CSF3 enhances the immune response to ALV-J via the NFκB signaling pathway. (A) Western blot analysis of p52, p100, phosphorylated <t>p65</t> (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 overexpression in DF-1 cells. (B) Quantification of protein levels in (A) based on relative grayscale values. (C) Western blot analysis of p52, p100, phosphorylated p65 (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 knockdown in DF-1 cells. (D) Quantification of protein levels in (C) based on relative grayscale values. (D, E) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (D) or knockdown (E) in DF-1 cells. (F, G) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (F) or knockdown (G) in DF-1 cells. (H, I) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (H) or knockdown (I) in CEF cells. (J, K) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (J) or knockdown (K) in CEF cells. (L) Western blot analysis of STAT3, phosphorylated STAT3 (p-STAT3), env, β-actin, IκBα, p-IκBα, p-p65, p52, and p100 after STAT3 phosphorylation inhibition in CSF3-overexpressing DF-1 cells. (M) Quantification of protein levels in (L) based on relative grayscale values. Statistical significance was determined using a two-tailed unpaired Student’s t-test ( p < 0.05). * p < 0.05, **p < 0.01, *** p < 0.001.
    Rabbit Polyclonal Antibody Against P Nfκb Ser536, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody against p nfκb ser536/product/Bioss
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal antibody against p nfκb ser536 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc p nfκb
    CSF3 enhances the immune response to ALV-J via the NFκB signaling pathway. (A) Western blot analysis of p52, p100, phosphorylated <t>p65</t> (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 overexpression in DF-1 cells. (B) Quantification of protein levels in (A) based on relative grayscale values. (C) Western blot analysis of p52, p100, phosphorylated p65 (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 knockdown in DF-1 cells. (D) Quantification of protein levels in (C) based on relative grayscale values. (D, E) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (D) or knockdown (E) in DF-1 cells. (F, G) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (F) or knockdown (G) in DF-1 cells. (H, I) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (H) or knockdown (I) in CEF cells. (J, K) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (J) or knockdown (K) in CEF cells. (L) Western blot analysis of STAT3, phosphorylated STAT3 (p-STAT3), env, β-actin, IκBα, p-IκBα, p-p65, p52, and p100 after STAT3 phosphorylation inhibition in CSF3-overexpressing DF-1 cells. (M) Quantification of protein levels in (L) based on relative grayscale values. Statistical significance was determined using a two-tailed unpaired Student’s t-test ( p < 0.05). * p < 0.05, **p < 0.01, *** p < 0.001.
    P Nfκb, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p nfκb/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    p nfκb - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology anti phospho rela ser536
    CSF3 enhances the immune response to ALV-J via the NFκB signaling pathway. (A) Western blot analysis of p52, p100, phosphorylated <t>p65</t> (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 overexpression in DF-1 cells. (B) Quantification of protein levels in (A) based on relative grayscale values. (C) Western blot analysis of p52, p100, phosphorylated p65 (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 knockdown in DF-1 cells. (D) Quantification of protein levels in (C) based on relative grayscale values. (D, E) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (D) or knockdown (E) in DF-1 cells. (F, G) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (F) or knockdown (G) in DF-1 cells. (H, I) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (H) or knockdown (I) in CEF cells. (J, K) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (J) or knockdown (K) in CEF cells. (L) Western blot analysis of STAT3, phosphorylated STAT3 (p-STAT3), env, β-actin, IκBα, p-IκBα, p-p65, p52, and p100 after STAT3 phosphorylation inhibition in CSF3-overexpressing DF-1 cells. (M) Quantification of protein levels in (L) based on relative grayscale values. Statistical significance was determined using a two-tailed unpaired Student’s t-test ( p < 0.05). * p < 0.05, **p < 0.01, *** p < 0.001.
    Anti Phospho Rela Ser536, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti phospho rela ser536/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    anti phospho rela ser536 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology antibodies against phospho rela ser536
    Figure 1. NF-κB is progressively activated in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. (A) Immunohistochemical analysis of total RELA protein expression in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. Scale bars: 200 µm for the left panels (100×) and 50 µm for the right panels (400×). (B) Statistical analysis of immunohistochemcal staining intensity (Mean OD) for total RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (C) Statistical analysis of the percentage of nuclear positivity for total RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (D) Immunohistochemical analysis of <t>p-RELA</t> protein expression in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. Scale bars: 200 µm for the left panels (100×) and 50 µm for the right panels (400×). (E) Statistical analysis of immunohistochemical staining intensity for p-RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (F) Statistical analysis of the percentage of nuclear positivity for p-RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. ns: no significance, * p < 0.05, ** p < 0.01, *** p < 0.001.
    Antibodies Against Phospho Rela Ser536, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against phospho rela ser536/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    antibodies against phospho rela ser536 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc p nfκb ser536
    Figure 1. NF-κB is progressively activated in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. (A) Immunohistochemical analysis of total RELA protein expression in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. Scale bars: 200 µm for the left panels (100×) and 50 µm for the right panels (400×). (B) Statistical analysis of immunohistochemcal staining intensity (Mean OD) for total RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (C) Statistical analysis of the percentage of nuclear positivity for total RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (D) Immunohistochemical analysis of <t>p-RELA</t> protein expression in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. Scale bars: 200 µm for the left panels (100×) and 50 µm for the right panels (400×). (E) Statistical analysis of immunohistochemical staining intensity for p-RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (F) Statistical analysis of the percentage of nuclear positivity for p-RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. ns: no significance, * p < 0.05, ** p < 0.01, *** p < 0.001.
    P Nfκb Ser536, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p nfκb ser536/product/Cell Signaling Technology Inc
    Average 99 stars, based on 1 article reviews
    p nfκb ser536 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    CSF3 enhances the immune response to ALV-J via the NFκB signaling pathway. (A) Western blot analysis of p52, p100, phosphorylated p65 (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 overexpression in DF-1 cells. (B) Quantification of protein levels in (A) based on relative grayscale values. (C) Western blot analysis of p52, p100, phosphorylated p65 (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 knockdown in DF-1 cells. (D) Quantification of protein levels in (C) based on relative grayscale values. (D, E) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (D) or knockdown (E) in DF-1 cells. (F, G) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (F) or knockdown (G) in DF-1 cells. (H, I) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (H) or knockdown (I) in CEF cells. (J, K) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (J) or knockdown (K) in CEF cells. (L) Western blot analysis of STAT3, phosphorylated STAT3 (p-STAT3), env, β-actin, IκBα, p-IκBα, p-p65, p52, and p100 after STAT3 phosphorylation inhibition in CSF3-overexpressing DF-1 cells. (M) Quantification of protein levels in (L) based on relative grayscale values. Statistical significance was determined using a two-tailed unpaired Student’s t-test ( p < 0.05). * p < 0.05, **p < 0.01, *** p < 0.001.

    Journal: Poultry Science

    Article Title: CSF3 enhances the innate immune responses to ALV-J infections via NF-κB and interferon pathways

    doi: 10.1016/j.psj.2025.105648

    Figure Lengend Snippet: CSF3 enhances the immune response to ALV-J via the NFκB signaling pathway. (A) Western blot analysis of p52, p100, phosphorylated p65 (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 overexpression in DF-1 cells. (B) Quantification of protein levels in (A) based on relative grayscale values. (C) Western blot analysis of p52, p100, phosphorylated p65 (p-p65), IκBα, and phosphorylated IκBα (p-IκBα) protein following CSF3 knockdown in DF-1 cells. (D) Quantification of protein levels in (C) based on relative grayscale values. (D, E) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (D) or knockdown (E) in DF-1 cells. (F, G) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (F) or knockdown (G) in DF-1 cells. (H, I) RT-qPCR analysis of TNF-α, IL-1β , and IL-6 mRNA expression following CSF3 overexpression (H) or knockdown (I) in CEF cells. (J, K) ELISA measurement of TNF-α, IL-1β, and IL-6 protein levels following CSF3 overexpression (J) or knockdown (K) in CEF cells. (L) Western blot analysis of STAT3, phosphorylated STAT3 (p-STAT3), env, β-actin, IκBα, p-IκBα, p-p65, p52, and p100 after STAT3 phosphorylation inhibition in CSF3-overexpressing DF-1 cells. (M) Quantification of protein levels in (L) based on relative grayscale values. Statistical significance was determined using a two-tailed unpaired Student’s t-test ( p < 0.05). * p < 0.05, **p < 0.01, *** p < 0.001.

    Article Snippet: Mouse Anti-ALV-J envelope protein JE9 (kindly provided by Prof. Aijian Qin, Yangzhou University, Yangzhou, China), Rabbit Anti-STAT3 antibody (bs-1141R; Boss, China; 1:1000), Rabbit Anti-phospho-STAT3 (Ser727) antibody (bs-3429R; Boss, China; 1:1000), Rabbit Anti-NFκB2 antibody (10037P, Boss, China; 1:1000), Rabbit Anti-NFκB p-p65 (bs-0982R, Boss, China; 1:1000), Rabbit Anti-IKBα Rabbit (10268-1-AP, Proteintech, USA; 1:1000), Anti-p-IKBα (bs-2513R, Boss, China; 1:1000), and goat anti-rabbit IgG/HRP (bs13278), goat anti-mouse IgG/HRP (bs12478), goat Anti-Mouse IgG ( H + L ) FITC (bs10950) secondary antibody were purchased from Bioss (Beijing, China).

    Techniques: Western Blot, Over Expression, Knockdown, Quantitative RT-PCR, Expressing, Enzyme-linked Immunosorbent Assay, Phospho-proteomics, Inhibition, Two Tailed Test

    Figure 1. NF-κB is progressively activated in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. (A) Immunohistochemical analysis of total RELA protein expression in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. Scale bars: 200 µm for the left panels (100×) and 50 µm for the right panels (400×). (B) Statistical analysis of immunohistochemcal staining intensity (Mean OD) for total RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (C) Statistical analysis of the percentage of nuclear positivity for total RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (D) Immunohistochemical analysis of p-RELA protein expression in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. Scale bars: 200 µm for the left panels (100×) and 50 µm for the right panels (400×). (E) Statistical analysis of immunohistochemical staining intensity for p-RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (F) Statistical analysis of the percentage of nuclear positivity for p-RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. ns: no significance, * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: International journal of molecular sciences

    Article Title: NF-κB Activation Is Essential for Cervical Cell Proliferation and Malignant Transformation.

    doi: 10.3390/ijms26062493

    Figure Lengend Snippet: Figure 1. NF-κB is progressively activated in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. (A) Immunohistochemical analysis of total RELA protein expression in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. Scale bars: 200 µm for the left panels (100×) and 50 µm for the right panels (400×). (B) Statistical analysis of immunohistochemcal staining intensity (Mean OD) for total RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (C) Statistical analysis of the percentage of nuclear positivity for total RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (D) Immunohistochemical analysis of p-RELA protein expression in normal, hyperplastic, CIN1, CIN2, CIN3, and CSCC tissues. Scale bars: 200 µm for the left panels (100×) and 50 µm for the right panels (400×). (E) Statistical analysis of immunohistochemical staining intensity for p-RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. (F) Statistical analysis of the percentage of nuclear positivity for p-RELA in normal, hyperplastic, CIN1-3, and CSCC tissues. ns: no significance, * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: The cells were then incubated overnight at 4 ◦C with primary antibodies against phospho-RELA (ser536) (sc-136548, Santa Cruz Biotechnolog, Santa Cruz, CA, USA), FN1 (WL00712a, Wanleibio, Shenyang, China), PLAU (WL02483, Wanleibio, China), ICAM1 (WL02268, Wanleibio, China), and Ki67 (WL1384a, Wanleibio, China).

    Techniques: Immunohistochemical staining, Expressing, Staining

    Figure 3. Short-term activation of NF-κB promotes the proliferation and migration of HcerEpic cells. (A) RT-qPCR experiment detecting the upregulation of RELA mRNA levels in HcerEpic cells treated with LPS (500 ng/mL). (B) Immunocytochemical experiment detecting the positive expression levels of RELA and p-RELA in HcerEpic cells stimulated by LPS. ImageJ software was used to quantify the percentage area (%Area) of positive expression areas of RELA and p-RELA. (C) CCK-8 assay detecting the effect of different concentrations of LPS on the proliferative ability of HcerEpic cells. (D) Calculation of the EC50 curve for HcerEpic cells treated with LPS based on cell viability. (E) LPS treatment promotes the expression of Ki67 protein in HcerEpic cells. (F) SC75741 treatment inhibits the promoting effect of LPS on the expression of RELA and p-RELA in HcerEpic cells. (G) Detection of HcerEpic cell viability under different concentrations of SC75741 and LPS co-treatment. (H) Scratch wound healing assay detecting the changes in migration ability of HcerEpic cells after LPS and SC75741 treatment. Scale bar: 20 µm. ** p < 0.01, *** p < 0.001.

    Journal: International journal of molecular sciences

    Article Title: NF-κB Activation Is Essential for Cervical Cell Proliferation and Malignant Transformation.

    doi: 10.3390/ijms26062493

    Figure Lengend Snippet: Figure 3. Short-term activation of NF-κB promotes the proliferation and migration of HcerEpic cells. (A) RT-qPCR experiment detecting the upregulation of RELA mRNA levels in HcerEpic cells treated with LPS (500 ng/mL). (B) Immunocytochemical experiment detecting the positive expression levels of RELA and p-RELA in HcerEpic cells stimulated by LPS. ImageJ software was used to quantify the percentage area (%Area) of positive expression areas of RELA and p-RELA. (C) CCK-8 assay detecting the effect of different concentrations of LPS on the proliferative ability of HcerEpic cells. (D) Calculation of the EC50 curve for HcerEpic cells treated with LPS based on cell viability. (E) LPS treatment promotes the expression of Ki67 protein in HcerEpic cells. (F) SC75741 treatment inhibits the promoting effect of LPS on the expression of RELA and p-RELA in HcerEpic cells. (G) Detection of HcerEpic cell viability under different concentrations of SC75741 and LPS co-treatment. (H) Scratch wound healing assay detecting the changes in migration ability of HcerEpic cells after LPS and SC75741 treatment. Scale bar: 20 µm. ** p < 0.01, *** p < 0.001.

    Article Snippet: The cells were then incubated overnight at 4 ◦C with primary antibodies against phospho-RELA (ser536) (sc-136548, Santa Cruz Biotechnolog, Santa Cruz, CA, USA), FN1 (WL00712a, Wanleibio, Shenyang, China), PLAU (WL02483, Wanleibio, China), ICAM1 (WL02268, Wanleibio, China), and Ki67 (WL1384a, Wanleibio, China).

    Techniques: Activation Assay, Migration, Quantitative RT-PCR, Expressing, Software, CCK-8 Assay, Wound Healing Assay

    Figure 4. Long-term activation of NF-κB promotes the expression of oncogenes in HcerEpic cells. (A) Immunocytochemical experiment detecting the changes in protein expression of p-RELA, Ki67, FN1, PLAU, and ICAM1 in HcerEpic cells after 1, 3, and 7 days of LPS treatment. (B) Western blot experiment detecting the changes in protein expression of RELA, p-RELA, FN1, PLAU, and ICAM1 in HcerEpic cells after 1, 3, and 7 days of LPS treatment. (C) Immunocytochemical experiment detecting the changes in protein expression of p-RELA, Ki67, FN1, PLAU, and ICAM1 in HcerEpic cells treated with LPS alone and in combination with SC75741. Scale bar: 20 µm. ns: no significance, * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: International journal of molecular sciences

    Article Title: NF-κB Activation Is Essential for Cervical Cell Proliferation and Malignant Transformation.

    doi: 10.3390/ijms26062493

    Figure Lengend Snippet: Figure 4. Long-term activation of NF-κB promotes the expression of oncogenes in HcerEpic cells. (A) Immunocytochemical experiment detecting the changes in protein expression of p-RELA, Ki67, FN1, PLAU, and ICAM1 in HcerEpic cells after 1, 3, and 7 days of LPS treatment. (B) Western blot experiment detecting the changes in protein expression of RELA, p-RELA, FN1, PLAU, and ICAM1 in HcerEpic cells after 1, 3, and 7 days of LPS treatment. (C) Immunocytochemical experiment detecting the changes in protein expression of p-RELA, Ki67, FN1, PLAU, and ICAM1 in HcerEpic cells treated with LPS alone and in combination with SC75741. Scale bar: 20 µm. ns: no significance, * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: The cells were then incubated overnight at 4 ◦C with primary antibodies against phospho-RELA (ser536) (sc-136548, Santa Cruz Biotechnolog, Santa Cruz, CA, USA), FN1 (WL00712a, Wanleibio, Shenyang, China), PLAU (WL02483, Wanleibio, China), ICAM1 (WL02268, Wanleibio, China), and Ki67 (WL1384a, Wanleibio, China).

    Techniques: Activation Assay, Expressing, Western Blot

    Figure 6. NF-κB regulates the expression of oncogenic DEGs and malignant phenotypes in cervical squamous cancer cells. (A,B) Western blot detecting the expression of RELA, p-RELA, E-cadherin, N- cadherin, FN1, ICAM1, and PLAU in SiHa and CasKi cells. (C) CCK-8 assay detecting the proliferative ability of SiHa and CasKi cells after treatment with different concentrations of SC75741 for 24 and 48 h. (D) Representative images of wound healing in SiHa and CasKi cells after scratch injury for 36 and 72 h in control and SC75741 treatment groups. Scale bar: 100 µm. (E) Colonies formed by SiHa and CasKi cells in control and SC75741 treatment groups. Data represent three replicates of a representative experiment. ns: no significance, * p < 0.05, ** p < 0.01, *** p < 0.001.

    Journal: International journal of molecular sciences

    Article Title: NF-κB Activation Is Essential for Cervical Cell Proliferation and Malignant Transformation.

    doi: 10.3390/ijms26062493

    Figure Lengend Snippet: Figure 6. NF-κB regulates the expression of oncogenic DEGs and malignant phenotypes in cervical squamous cancer cells. (A,B) Western blot detecting the expression of RELA, p-RELA, E-cadherin, N- cadherin, FN1, ICAM1, and PLAU in SiHa and CasKi cells. (C) CCK-8 assay detecting the proliferative ability of SiHa and CasKi cells after treatment with different concentrations of SC75741 for 24 and 48 h. (D) Representative images of wound healing in SiHa and CasKi cells after scratch injury for 36 and 72 h in control and SC75741 treatment groups. Scale bar: 100 µm. (E) Colonies formed by SiHa and CasKi cells in control and SC75741 treatment groups. Data represent three replicates of a representative experiment. ns: no significance, * p < 0.05, ** p < 0.01, *** p < 0.001.

    Article Snippet: The cells were then incubated overnight at 4 ◦C with primary antibodies against phospho-RELA (ser536) (sc-136548, Santa Cruz Biotechnolog, Santa Cruz, CA, USA), FN1 (WL00712a, Wanleibio, Shenyang, China), PLAU (WL02483, Wanleibio, China), ICAM1 (WL02268, Wanleibio, China), and Ki67 (WL1384a, Wanleibio, China).

    Techniques: Expressing, Western Blot, CCK-8 Assay, Control